COX-2 and cancer: a new approach to an old problem

Br J Pharmacol. 2001 Nov;134(6):1137-50. doi: 10.1038/sj.bjp.0704365.

Author

Y S Bakhle¹

Affiliation

¹ Leukocyte Biology, Division of Biomedical Sciences, Faculty of Medicine, Imperial College, London SW7 2AZ. y.bakhle@ic.ac.uk

No abstract available

Publication types

Review

MeSH terms

Animals
Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
Aspirin / pharmacology*
Colorectal Neoplasms / drug therapy
Colorectal Neoplasms / enzymology
Colorectal Neoplasms / etiology*
Cyclooxygenase 2
Epidemiologic Studies
Humans
Isoenzymes / metabolism*
Membrane Proteins
Prostaglandin-Endoperoxide Synthases / metabolism*
Prostaglandins / biosynthesis*
Receptors, Cytoplasmic and Nuclear / drug effects*
Transcription Factors / drug effects*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Isoenzymes
Membrane Proteins
Prostaglandins
Receptors, Cytoplasmic and Nuclear
Transcription Factors
Cyclooxygenase 2
PTGS2 protein, human
Prostaglandin-Endoperoxide Synthases
Aspirin